Clicky

Soleno Therapeutics, Inc.(SLNO) News

Date Title
May 26 EMA validates Soleno’s application for Prader-Willi syndrome treatment
May 23 Soleno Therapeutics seeking regulatory approval in treatment of PWS
May 23 Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR
May 22 Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
Apr 23 Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET
Apr 14 Soleno Therapeutics Announces VYKAT(TM) XR Launch
Apr 1 High Growth Tech Stocks To Watch In The US April 2025
Mar 30 Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week?
Mar 29 Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday?
Mar 28 Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?
Mar 27 Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, But Aardvark Reverses Lower
Mar 27 Tiny Drugmaker Soars on FDA Win to Treat Never-Ending Hunger
Mar 27 Soleno wins FDA approval for Prader-Willi hyperphagia treatment
Mar 27 Soleno stock skyrockets on FDA drug approval
Mar 27 SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug
Mar 26 Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome
Mar 3 Exploring US High Growth Tech Stocks In March 2025
Feb 27 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
Oct 9 SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA
Oct 8 Why Soleno Therapeutics Stock Blasted 9% Higher Today